New Delhi, March 17 (NationPress) The Delhi High Court has issued a notice regarding a contempt petition that claims non-compliance with a previous order mandating the Central Drugs Standard Control Organisation (CDSCO) to investigate the safety and regulatory matters associated with the use of specific diabetes medications for weight management.

A single-judge bench led by Justice Sachin Datta has requested replies from the Drugs Controller General of India (DCGI) and Union Health Secretary Punya Salila Srivastava, allowing them four weeks to respond.

The case is scheduled for further examination on May 21.

The contempt petition, submitted by advocate Rohit Kumar, asserts that the authorities did not adhere to the Delhi High Court's directive from July 2025, which called for a decision regarding regulatory concerns related to the usage of GLP-1 receptor agonist medications for weight management and cosmetic purposes.

The petition notes that a prior bench comprising Chief Justice Devendra Upadhyaya and Justice Tushar Rao Gedela had previously authorized the petitioner to provide supplementary documentation with pertinent information and instructed the competent authority to review it in accordance with the law, consult experts and stakeholders—including manufacturers—and make a decision within three months of submission.

In representing the petitioner, the counsel indicated that despite explicit judicial instructions, there have been no substantial actions taken over several months.

It was highlighted that even though a supplementary representation was submitted on July 13, 2025, the relevant authorities did not act within the stipulated three-month timeframe.

The contempt petition pointed out significant issues, including the exemption from India-specific clinical trials as per the New Drugs and Clinical Trials Rules, 2019, potential gaps in pharmacovigilance measures, regulatory inconsistencies, and aggressive marketing practices.

Furthermore, it was stated that no acknowledgment was received from the authorities, even after follow-ups, including an email sent on January 29, 2026.

With nearly eight months elapsed since the representation was submitted, the petitioner argued that this ongoing inaction constitutes a willful defiance of the Delhi High Court's binding orders.

The petition emphasized that the ruling issued on July 2, 2025, imposed a "clear and time-sensitive obligation" on CDSCO to reach a decision within three months, asserting that "mere internal processing or informal communications indicating the matter is under review do not fulfill compliance with a binding judicial directive."